 JERUSALEM, Israel, July 16, 2019 PRNewswire -- BiondVax Pharmaceuticals Ltd. BVXV is proud to announce today the results of its previously announced rights offering. The Company has received subscriptions from existing shareholders for all the offered American Depositary Shares ADSs and ordinary shares, being a total of 3,057,466 ADSs and 18,298,898 ordinary shares, raising total gross proceeds of US20 Million. 